Los Angeles Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-23,601
| Closed | -$307K | – | 1233 |
|
|
2024
Q2 | $307K | Sell |
23,601
-2,234
| -9% | -$29.1K | ﹤0.01% | 1005 |
|
|
2024
Q1 | $585K | Sell |
25,835
-268
| -1% | -$6.07K | ﹤0.01% | 829 |
|
|
2023
Q4 | $339K | Buy |
+26,103
| New | +$339K | ﹤0.01% | 978 |
|
|
2023
Q2 | – | Sell |
-7,582
| Closed | -$442K | – | 1228 |
|
|
2023
Q1 | $442K | Buy |
7,582
+788
| +12% | +$46K | ﹤0.01% | 890 |
|
|
2022
Q4 | $347K | Buy |
6,794
+1,550
| +30% | +$79.1K | ﹤0.01% | 998 |
|
|
2022
Q3 | $429K | Buy |
5,244
+3,999
| +321% | +$327K | ﹤0.01% | 964 |
|
|
2022
Q2 | $84K | Hold |
1,245
| – | – | ﹤0.01% | 1292 |
|
|
2022
Q1 | $138K | Buy |
+1,245
| New | +$138K | ﹤0.01% | 1377 |
|
|
2020
Q2 | – | Sell |
-974
| Closed | -$281K | – | 1491 |
|
|
2020
Q1 | $281K | Buy |
974
+165
| +20% | +$47.6K | ﹤0.01% | 1076 |
|
|
2019
Q4 | $233K | Buy |
+809
| New | +$233K | ﹤0.01% | 1173 |
|
|
2019
Q1 | – | Sell |
-4,589
| Closed | -$645K | – | 1401 |
|
|
2018
Q4 | $645K | Buy |
4,589
+1,916
| +72% | +$269K | ﹤0.01% | 886 |
|
|
2018
Q3 | $683K | Buy |
2,673
+462
| +21% | +$118K | ﹤0.01% | 1010 |
|
|
2018
Q2 | $564K | Buy |
+2,211
| New | +$564K | ﹤0.01% | 1102 |
|